PH12855A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
PH12855A
PH12855A PH19456A PH19456A PH12855A PH 12855 A PH12855 A PH 12855A PH 19456 A PH19456 A PH 19456A PH 19456 A PH19456 A PH 19456A PH 12855 A PH12855 A PH 12855A
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
PH19456A
Inventor
A Maass
N Ditullio
C Lowman
H Saunders
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of PH12855A publication Critical patent/PH12855A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PH19456A 1974-11-27 1977-02-16 Pharmaceutical compositions PH12855A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/527,560 US3969508A (en) 1974-11-27 1974-11-27 Lowering the concentration of plasma triglycerides

Publications (1)

Publication Number Publication Date
PH12855A true PH12855A (en) 1979-09-12

Family

ID=24101958

Family Applications (2)

Application Number Title Priority Date Filing Date
PH17786A PH11295A (en) 1974-11-27 1975-11-21 Method of producing hypolipidemic activity
PH19456A PH12855A (en) 1974-11-27 1977-02-16 Pharmaceutical compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PH17786A PH11295A (en) 1974-11-27 1975-11-21 Method of producing hypolipidemic activity

Country Status (10)

Country Link
US (1) US3969508A (en)
AU (1) AU499316B2 (en)
BE (1) BE835823A (en)
DE (1) DE2553101A1 (en)
FR (1) FR2292470A1 (en)
GB (1) GB1535203A (en)
IL (1) IL48518A (en)
NL (1) NL7513877A (en)
PH (2) PH11295A (en)
ZA (1) ZA757439B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1569404A (en) * 1977-04-22 1980-06-11 Soc D Etudes Prod Chimique (2-isopropyl-4-(2'-theonyl)-5-methyl) phenoxy acetic acid
US4089970A (en) * 1977-09-07 1978-05-16 Smithkline Corporation Method of inhibiting platelet aggregation
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB760114A (en) * 1953-06-19 1956-10-31 Chimie Atomistique Improvements in and relating to compositions for lowering the cholesterol level in the blood serum
US3402198A (en) * 1965-10-20 1968-09-17 William A. Bolhofer 2-(phenoxy), 2-(phenylthio) and 2-(anilino) substituted 2-alkylideneacetic acid derivatives
GB1228236A (en) * 1968-05-20 1971-04-15
BE757001A (en) * 1969-10-10 1971-03-16 Cerpha HETEROCYCLIC DERIVATIVES OF PHENOXY ACETIC ACIDS AND THEIR PREPARATION

Also Published As

Publication number Publication date
FR2292470A1 (en) 1976-06-25
IL48518A0 (en) 1976-01-30
US3969508A (en) 1976-07-13
GB1535203A (en) 1978-12-13
NL7513877A (en) 1976-05-31
AU499316B2 (en) 1979-04-12
DE2553101A1 (en) 1976-08-12
ZA757439B (en) 1976-11-24
IL48518A (en) 1978-08-31
AU8689475A (en) 1977-06-02
FR2292470B1 (en) 1978-11-10
BE835823A (en) 1976-05-21
PH11295A (en) 1977-11-02

Similar Documents

Publication Publication Date Title
ZA751806B (en) Pharmaceutical compositions
NZ179495A (en) 1-substituted-4-benzylpiperidines and pharmaceutical compositions
ZA74385B (en) Pharmaceutical compositions
ZA756572B (en) Shampoo compositions
ZA755998B (en) Pharmaceutical compositions
IL48508A (en) Pharmaceutical compositions comprising piperidylindole derivatives
AU487061B2 (en) Pharmaceutical compositions
PH12058A (en) Antibiotic pharmaceutical compositions
IL46965A (en) Pharmaceutical composition containing heparinoidic factor
IL47681A0 (en) Uv-photopolymerizable compositions
HK17281A (en) Pharmaceutical compositions
NZ179502A (en) Ii-desoxy-omega-tetra norprostaglanding internediates pharmaceutical composition
ZA755802B (en) Pharmaceutical compositions
IL48098A0 (en) Pharmaceutical compositions containing diphenylethanol derivatives
PH12855A (en) Pharmaceutical compositions
HK73178A (en) Pharmaceutical compositions
ZM12375A1 (en) Compositions
ZA755515B (en) Pharmaceutical formulations
NZ178962A (en) 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions
ZA757067B (en) Pharmaceutical compositions comprising substituted 4,6-dihydroxy-2h-pyran-2-ones
IE39123B1 (en) Pharmaceutical compositions
ZA755904B (en) Pharmaceutical compositions
ZA744340B (en) Pharmaceutical compositions
ZA756921B (en) Pharmaceutical compositions
ZA742246B (en) Pharmaceutical compositions